ADMP - Adamis Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.533M

Cash

3.10M

Avg Qtr Burn

-5.118M

Short % of Float

0.71%

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ZIMHI (naloxone 5mg) Details Opioid Overdose	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SYMJEPI (epinephrine 0.3mg and 0.15mg) Details Anaphylaxis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
APC-410 (tempol) Details Acute respiratory distress syndrome, Inflammatory disease, COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
APC-400 (tempol) Details Radiation Dermatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.